Performances of HCV Ag or HCV RNA kits for screening of HCV-infected samples

Chinese Journal of Biologicals

Volumn 27, Issue 9, 2014, Pages 1181-1184

  Gu, Jin Lian ^a   Yu, Yang ^a   Liang, Zheng Lun ^a  

^a NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

Author keywords

Antigen; Hepatitis virus, C; Nucleic acid

Indexed keywords

HEPATITIS C ANTIGEN; REAGENT; VIRUS RNA;

ARTICLE; BLOOD SAMPLING; DEVICE COMPARISON; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOASSAY ANALYZER; SCREENING TEST; SENSITIVITY ANALYSIS; VIRUS LOAD;

EID: 84909948474     PISSN: 10045503     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Jin ZL, Wang FC, Zhu FM. HCV core antigen in blood donors with negative HCV antibody [J]. Chin J Nosocomiol, 2005, 15 (8): 859-860. (in Chinese)
2. Long RX, Yang R, Bai HZ, et al. HCV RNA and core antigen (HCV-cAg) analysis in HCV-Ab positive samples [J]. J Med Res, 2010, 39(12): 41-43. (in Chinese)
3. Chen XY, Dou XC, Hu D, et al. Detection of hepatitis C virus core antigen and its clinical significance [J]. Chin J Viral Dis, 2013, 3(1): 12-16. (in Chinese)
4. Yang JF, Lin YY, Hsieh MH, et al. Performance characteristics of a combined hepatitis C virus core antigen and anti-hepatitis C virus antibody test in different patient groups [J]. Kaohsiung J Med Sci, 2011, 27 (7): 258-263.
5. Muerhoff AS, Jiang L, Shah DO, et al. Detection of HCV core antigen in human serum and plasma with an automated chemi luminescent immunoassay [J]. Transfusion, 2002, 42 (3): 349-356.
6. Morota K, Fujinami R, Kinukawa H, et al. A new sensitive and automated chemiluminescent microparticle immunoassay for quantitative determination of hepatitis C virus core antigen [J]. J Virol Methods, 2009, 157 (1): 8-14.
7. Mao YQ. Analysis on the detection results of HCV RNA, HCV core antigen and alanine ammotrans ferase [J]. Lab Med Clin, 2011, 8(22): 2711-2712. (in Chinese)
8. Vermehren J, Susser S, Berger A, et al. Clinical utility of the ARCHITECT HCV Ag assay for early treatment monitoring in patients with chronic hepatitis C genotype 1 infection [J]. J Clin Virol, 2012, 55(1): 17-22.
9. Saldanha J, Heath A, Aberham C, et al. World Health Organization collaborative study to establish a replacement WHO international standard for hepatitis C virus RNA nucleic acid amplification technology assays [J]. Vox Sang, 2005, 88(3): 202-204.
10. Krajden M, Shivji R, Cunadasa K, et al. Evaluation of the core antigen assay as a second-line supplemental test for diagnosis of active hepatitis C virus infection [J]. J Clin Microbiol, 2004, 42 (9): 4054-4059.
11. Wang Y, Dou HL, Xu J. Applied value of laboratory diagnosis on hepatitis C by combining ELISA-anti-HAC antibody with ELISA-HCV core antigen detection [J]. J Radioimmunol, 2012, 25(3): 279-281. (in Chinese)
12. Yan HY, OuYang Y, Liu XQ, et al. Joint detection of HCV-cAg, HCV-RNA and HCV-Ab in decreasing misdiagnosis rate of hepatitis C [J]. Chin J Heal Lab Technol, 2012, 22(10): 2412-2414. (in Chinese)
13. Bouvier-Alias M, Patel K, Dahari H, et al. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication [J]. Hepatology, 2002, 36 (1): 211-218.
14. Huang HC, Chuang CS, Hsieh YY, et al. Serum HCV RNA level is not associated with insulin resistance and metabolic syndrome in chronic hepatitis C patients with genotype 1 or 2 infection [J]. Chang Gung Med J, 2011, 34 (5) : 487-495.
15. Seiskari T, Horsti J, Aittoniemi J. The value of HCV antigen test with reference to PCR in confirming infection in cases with indefinite antibody test result [J]. J Clin Virol, 2011, 51 (1): 90-91.